{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T18:10:16Z","timestamp":1778523016143,"version":"3.51.4"},"reference-count":49,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Autoimmune pancreatitis (AIP) represents a rare multifaceted disorder group with currently three types that were recently supplemented by a newly described AIP type causally related to sunlight exposure, not previously reported in any of the AIP publications. The internet search disclosed that the new AIP type was different from three existing AIP types: the AIP-1 or AIP-2 types, both featured by idiopathy, and the AIP-3 type, triggered by immune checkpoint inhibitors. Accordingly, it seemed appropriate to classify the novel AIP as the AIP-4 type, with typical features such as a clear culprit of sunlight exposure, ascertained by a positive result of an unintentional re-exposure and considered a diagnostic gold standard; coexisting secondary sclerosing cholangitis without progression to vanishing bile duct syndrome; and ultimately unavoidable pancreatic atrophy with clinical exocrine insufficiency despite long-term treatment with immunosuppressive drugs. Thus, the recent description of a new AIP type, now classified as the AIP-4 type, is strongly associated with significant sunlight exposure and calls for a reclassification of AIP types that includes AIP-4, whereby additional efforts are essential to identify the causative factors of the AIP-1 and AIP-2 types, including drugs commonly used in the respective cohorts, which also comprise older patients with comorbidities.<\/jats:p>","DOI":"10.3390\/ijms27093992","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T08:03:47Z","timestamp":1777536227000},"page":"3992","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Autoimmune Pancreatitis Re-Classification with Novel Type AIP-4"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8910-1200","authenticated-orcid":false,"given":"Rolf","family":"Teschke","sequence":"first","affiliation":[{"name":"Department of Internal Medicine II, Division of Gastroenterology and Hepatology, Klinikum Hanau, 63450 Hanau, Germany"},{"name":"Academic Teaching Hospital of the Medical Faculty, Goethe University Frankfurt\/Main, 60323 Frankfurt am Main, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Vemulapalli, V., Natha, C., and Thomas, A.S. (2025). Autoimmune pancreatitis: A Review. J. Clin. Med., 14.","DOI":"10.3390\/jcm14093076"},{"key":"ref_2","first-page":"1751","article-title":"Autoimmune pancreatitis novelty as triggered by sunlight exposure in a patient with verified causality by unintentional re-exposure as diagnostic gold standard: A case report","volume":"10","author":"Teschke","year":"2026","journal-title":"Clin. Case Rep. Int."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Nista, E.C., De Lucia, S.S., Manilla, V., Schepis, T., Pellegrino, A., Ojetti, V., Pignataro, G., Zileri Dal Verme, L., Franceschi, F., and Gasbarrini, A. (2022). Autoimmune pancreatitis: From pathogenesis to treatment. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232012667"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"817","DOI":"10.3748\/wjg.v30.i8.817","article-title":"Autoimmune pancreatitis: Cornerstones and future perspectives","volume":"30","author":"Gallo","year":"2024","journal-title":"World J. Gastroenterol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"357","DOI":"10.5009\/gnl210241","article-title":"Type 2 autoimmune pancreatitis: Consensus and controversies","volume":"16","author":"Zen","year":"2022","journal-title":"Gut Liver"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ueg2.12504","article-title":"Clinical features and long-term outcomes of patients with type 2 autoimmune pancreatitis","volume":"12","author":"Carlin","year":"2024","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e858","DOI":"10.1097\/MEG.0000000000002280","article-title":"Immune-related cholangitis induced by immune checkpoint inhibitors: A systematic review of clinical features and management","volume":"33","author":"Pi","year":"2021","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1111\/apt.18276","article-title":"Time to use the right classification to predict the severity of checkpoint inhibitor-induced liver injury, as assessed for causality using the updated RUCAM","volume":"60","author":"Hountondji","year":"2024","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Liu, Z., Zhu, Y., Xie, H., and Zou, Z. (2023). Immune-mediated hepatitis induced by immune checkpoint inhibitors: Current updates and futures perspectives. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.1077468"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pan.2016.12.003","article-title":"International consensus for the treatment of autoimmune pancreatitis","volume":"17","author":"Okazaki","year":"2017","journal-title":"Pancreatology"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00535-022-01857-9","article-title":"Amendment of the Japanese consensus guidelines for autoimmune pancreatitis, 2020","volume":"57","author":"Okazaki","year":"2022","journal-title":"J. Gastroenterol."},{"key":"ref_12","unstructured":"IAP\/APA\/EPC\/IPC\/JPS Working Group (2025). International Association of Pancreatology Revised Guidelines on Acute Pancreatitis 2025: Supported and Endorsed by the American Pancreatic Association, European Pancreatic Club, Indian Pancreas Club, and Japan Pancreas Society. Pancreatology, 25, 770\u2013814."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1038\/ctg.2017.17","article-title":"Azathioprine maintenance therapy to prevent relapses in autoimmune pancreatitis","volume":"8","author":"Amodio","year":"2017","journal-title":"Clin. Transl. Gastroenterol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.advms.2020.07.002","article-title":"Autoimmune pancreatitis\u2014An ongoing challenge","volume":"65","author":"Blaho","year":"2020","journal-title":"Adv. Med. Sci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/MPA.0b013e3182142fd2","article-title":"International consensus diagnostic criteria for autoimmune pancreatitis: Guidelines of the International Association of Pancreatology","volume":"40","author":"Shimosegawa","year":"2011","journal-title":"Pancreas"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Danan, G., and Teschke, R. (2016). RUCAM in drug and herb induced liver injury: The update. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17010014"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1001\/jama.2019.19411","article-title":"Diagnosis and management of chronic pancreatitis: A review","volume":"322","author":"Singh","year":"2019","journal-title":"JAMA"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Bruni, A., Colecchia, L., Dell\u2019Anna, G., Scalvini, D., Mandarino, F.V., Lisotti, A., Fuccio, L., Cecinato, P., Marasco, G., and Donatelli, G. (2025). Nutritional management in chronic pancreatitis: From exocrine pancreatic insufficiency to precision therapy. Nutrients, 17.","DOI":"10.3390\/nu17172720"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Grebenciucova, E., and VanHaerents, S. (2023). Interleukin 6: At the interface of human health and disease. Front. Immunol., 14.","DOI":"10.3389\/fimmu.2023.1255533"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"6867","DOI":"10.3748\/wjg.v28.i48.6867","article-title":"Recent advances in the management of autoimmune pancreatitis in the era of artificial intelligence","volume":"28","author":"Mack","year":"2022","journal-title":"World J. Gastroenterol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ymgme.2019.01.004","article-title":"Porphyria cutanea tarda: Recent update","volume":"128","author":"Singal","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.bpg.2010.07.002","article-title":"Porphyria cutanea tarda\u2014When skin meets liver","volume":"24","author":"Frank","year":"2010","journal-title":"Best Pr. Res. Clin. Gastroenterol."},{"key":"ref_23","first-page":"339","article-title":"Liver injury in immune Stevens-Johnson syndrome and toxic epidermal necrolysis: Five new classification types","volume":"13","author":"Teschke","year":"2025","journal-title":"J. Clin. Transl. Hepatol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Teschke, R. (2025). Immunology highlights of four major idiosyncratic DILI subtypes verified by the RUCAM: A new evidence-based classification. Livers, 5.","DOI":"10.3390\/livers5010008"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s40001-023-01142-2","article-title":"Photodistributed Stevens-Johnson syndrome and toxic epidermal necrolysis: A systematic review and proposal for a new diagnostic classification","volume":"28","author":"McKinley","year":"2023","journal-title":"Eur. J. Med. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"24518","DOI":"10.1038\/s41598-025-10478-0","article-title":"Clinicopathological features of type 1 autoimmune pancreatitis without elevated serum IgG4 level","volume":"15","author":"Yamashita","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s00534-012-0521-y","article-title":"Clinical diagnostic criteria of IgG4-related sclerosing cholangitis 2012","volume":"19","author":"Ohara","year":"2012","journal-title":"J. Hepatobiliary Pancreat Sci."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00535-022-01891-7","article-title":"Current status of type 1 (IgG4-related) autoimmune pancreatitis","volume":"57","author":"Uchida","year":"2022","journal-title":"J. Gastroenterol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3030","DOI":"10.1111\/jgh.70125","article-title":"Clinical Profile and predictors of repeated relapse in type 1 autoimmune pancreatitis: A multicenter observational study","volume":"40","author":"Saeki","year":"2025","journal-title":"J. Gastroenterol. Hepatol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s00535-021-01817-9","article-title":"The clinical efficacy of azathioprine as maintenance treatment for autoimmune pancreatitis: A systematic review and meta-analysis","volume":"56","author":"Masaki","year":"2021","journal-title":"J. Gastroenterol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.2169\/internalmedicine.41.1142","article-title":"Autoimmune pancreatitis successfully treated with ursodeoxycholic acid","volume":"41","author":"Tsubakio","year":"2002","journal-title":"Intern. Med."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Wu, S., Qin, X., Jin, Z., and Yang, L. (2025). A comprehensive review of IgG4-related pancreatitis: Pathogenesis, diagnosis, and therapeutic advances. Front. Immunol., 16.","DOI":"10.3389\/fimmu.2025.1590902"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/ueg2.12537","article-title":"Autoimmune pancreatitis-New evidence for clinical management strategies","volume":"12","author":"Hamm","year":"2024","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.2214\/AJR.19.21519","article-title":"IgG4-related sclerosing cholangitis: A clinical and imaging review","volume":"213","author":"Madhusudhan","year":"2019","journal-title":"Am. J. Roentgenol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1097\/MOG.0000000000000873","article-title":"Type 3 autoimmune pancreatitis (immune checkpoint inhibitor-induced pancreatitis)","volume":"38","author":"Abreo","year":"2022","journal-title":"Curr. Opin. Gastroenterol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2169\/internalmedicine.3591-24","article-title":"Immunoglobulin G4-related autoimmune pancreatitis and hypopituitarism following immune checkpoint inhibitor therapy","volume":"64","author":"Inoue","year":"2025","journal-title":"Intern. Med."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/hepr.14078","article-title":"Diagnostic guide for immune checkpoint inhibitor-induced liver injury","volume":"54","author":"Ito","year":"2024","journal-title":"Hepatol. Res."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"e378","DOI":"10.1097\/MPA.0000000000002582","article-title":"Immune checkpoint inhibitor-induced pancreatic injury: An emerging form of immune-mediated pancreatitis","volume":"55","author":"Alsaleh","year":"2026","journal-title":"Pancreas"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s40425-019-0502-7","article-title":"Clinical characteristics and outcomes of immune checkpoint inhibitor-induced pancreatic injury","volume":"7","author":"Tang","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e70073","DOI":"10.1111\/liv.70073","article-title":"Ursodeoxycholic acid alone is effective and safe to treat cholestatic checkpoint inhibitor-induced liver injury","volume":"45","author":"Hountondji","year":"2025","journal-title":"Liver Int."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"e0518","DOI":"10.1097\/HC9.0000000000000518","article-title":"Drug-Induced Liver Injury Network. Genetic variants associated with immune-mediated liver injury from checkpoint inhibitors","volume":"8","author":"Fontana","year":"2024","journal-title":"Hepatol. Commun."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1053\/j.gastro.2022.09.042","article-title":"Autoimmune pancreatitis secondary to immune checkpoint inhibitor therapy (type 3 AIP): Insights into a new disease from serial pancreatic imaging","volume":"164","author":"Thomas","year":"2023","journal-title":"Gastroenterology"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s11894-023-00885-6","article-title":"Immune checkpoint inhibitor-induced (type 3) autoimmune pancreatitis","volume":"25","author":"Thomas","year":"2023","journal-title":"Curr. Gastroenterol. Rep."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1002\/hep.30189","article-title":"Antiprogrammed cell death-1 immunotherapy-related secondary sclerosing cholangitis","volume":"69","author":"Ogawa","year":"2019","journal-title":"Hepatology"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"940831","DOI":"10.1155\/2012\/940831","article-title":"Autoantibodies in autoimmune pancreatitis","volume":"2012","author":"Smyk","year":"2012","journal-title":"Int. J. Rheumatol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1002\/ueg2.12738","article-title":"Update on autoimmune pancreatitis and IgG4-related disease","volume":"13","author":"Lanzillotta","year":"2025","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Fang, W., Wang, H., Zhang, X., Zhu, H., Yan, W., and Gao, Y. (2025). Immune checkpoint inhibitors-induced pancreatitis: A systematic review and real-world pharmacovigilance analysis. Front. Pharmacol., 16.","DOI":"10.3389\/fphar.2025.1426847"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/CJI.0000000000000472","article-title":"Immune Checkpoint inhibitor-related pancreatitis: A case series, review of the literature and an expert opinion","volume":"46","author":"Kramer","year":"2023","journal-title":"J. Immunother."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1093\/oncolo\/oyad150","article-title":"Exocrine Pancreatic insufficiency induced by immune checkpoint inhibitors","volume":"28","author":"Satish","year":"2023","journal-title":"Oncologist"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/9\/3992\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T17:21:58Z","timestamp":1778520118000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/9\/3992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":49,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["ijms27093992"],"URL":"https:\/\/doi.org\/10.3390\/ijms27093992","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]}}}